Clinical trial
A Multi-Center, Randomized, Controlled Clinical Trial of the Safety and Efficacy of Regen Sling Treatment for Female Patients With Stress Urinary Incontinence
NCT02106299 is registered in ClinicalTrials.gov with Medprin Regenerative Medical Technologies Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Controlled Clinical Trial of the Safety and Efficacy of Regen Sling Treatment for Female Patients With Stress Urinary Incontinence
- Lead sponsor
- Medprin Regenerative Medical Technologies Co., Ltd.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- December 31, 2015
- Enrollment
- 178 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stress urinary incontinence